For Immediate Release: August 1st, 2018
Contact: Dr. Jahan Marcu | 215-828-9183 | Jahan@safeaccessnow.org
California Laboratory Achieves National Certification
Los Angeles, CA – Americans for Safe Access (ASA) is pleased to announce that Consumer Safety Analytics (AKA CannaSafe) Laboratory of Van Nuys, California has been certified for laboratory analysis of medical cannabis products under ASA’s Patient Focused Certification (PFC) program. PFC is a project of ASA, and the only nonprofit, third-party certification program for the medical cannabis industry based on quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopoeia (AHP).
Washington, DC — The Food and Drug Administration (FDA) has approved a drug that contains an active ingredient derived from the cannabis plant. The drug, Epidiolex, an oral solution containing cannabidiol (CBD), will be the first and only FDA-approved CBD drug on the market. The FDA has approved Epidiolex for use only in the treatment of two rare seizure disorders (Dravet Syndrome and Lennox-Gastaut Syndrome), and is the first FDA-approved treatment for patients suffering from Dravet syndrome. While there have been other medications that mimic the natural cannabinoids found in cannabis that have received FDA approval, Epidiolex is the first non-synthetic medication to be derived directly from the cannabis plant. The FDA’s approval of Epidiolex shows that it is possible to make medications from complex plant extracts.
Senators Warren and Gardner Release STATES Act to Respect State Cannabis Laws - Americans for Safe Access
Washington, DC — U.S. Senators Elizabeth Warren (D-MA) and Cory Gardner (R-CO) introduced the Strengthening the Tenth Amendment Through Entrusting States Act (STATES Act) to respect state determinations about cannabis policy. The bill was also introduced in the House of Representatives by David Joyce (R-OH) and Earl Blumenauer (D-OR).
International Medical Cannabis Advocates Address WHO Committee Set to Advise UN
Geneva, Switzerland — Yesterday, Americans for Safe Access (ASA), along with members of the International Medical Cannabis Patients Coalition (IMCPC), attended and delivered testimony at the 40th meeting of the World Health Organization's (WHO) Expert Committee on Drug Dependence (ECDD) being held in Geneva, Switzerland, June 4-7th, 2018.
In a milestone moment for medical cannabis patients, the ECDD will be reviewing and assessing the medical uses and harms of Cannabis, in order to recommend the most appropriate classification to be applied internationally. The agenda of the meeting is dedicated to carrying out pre-reviews of cannabis and cannabis-related substances. Members of ASA and IMCPC produced and delivered 1 Critical Review and 3 Pre-Review reports on Cannabidiol (CBD), Cannabis plant and cannabis resin, Extracts and tinctures of cannabis, and Delta-9-tetrahydrocannabinol (THC), which included references and recommendations for the committee to use in their review.
Medical Cannabis Patients, Medical Professionals, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C. - Americans for Safe Access
May 22 - May 25, 2018
Contact: Debbie Churgai | 202-857-4272 x.8 | firstname.lastname@example.org
WASHINGTON, DC — Starting on Tuesday, May 22nd and running until Friday, May 25th, medical cannabis patients, advocates, medical and legal professionals, and industry business leaders will gather at Americans for Safe Access’ (ASA) Annual National Medical Cannabis Unity conference in Washington, D.C. to learn and exchange ideas about how to navigate and steer medical cannabis policy in this ever-changing political landscape.
What: 6th Annual National Medical Cannabis Unity Conference
Where: Omni Shoreham Hotel in Washington, DC,
When: Tuesday, May 22nd through Friday, May 25th
This year's conference will focus on the life-saving role that medical cannabis can play in the fight against the Opioid Epidemic. In 2017 ASA launched the End Pain, Not Lives campaign, to help protect current medical cannabis programs, remove barriers for people with pain, chronic pain, and Opioid Use Disorder, and to educate medical professionals, service providers, and patients about medical cannabis and pain.
Americans For Safe Access Responds to Trump’s Commitment to Respect State Cannabis Laws - Americans for Safe Access
Washington, DC — Senator Cory Gardner (R-CO) revealed today that in a recent phone conversation with President Trump, the President expressed support for letting states decide their own policies when it comes to cannabis. Senator Gardner has been blocking the confirmation of key nominees to the Department of Justice since Attorney General Sessions rescinded the Cole Memorandum earlier this year. President Trump’s comments to Senator Gardner are in direct contrast of those previously stated by Attorney General Jeff Sessions, including "good people don’t smoke marijuana."
Research Continues to Show Benefits of Cannabis in Fighting the Opioid Crisis - Americans for Safe Access
Washington, DC — New research has been released that further highlights the potential role of medical cannabis in combating the Nation’s opioid crisis . Two studies, published on April 2nd by the Journal of the American Medical Association reveal a net decrease in opioid prescriptions in states with medical cannabis laws for Medicare and Medicaid populations.
Media Advisory for: March 22, 2018
Contact: David Mangone | email@example.com | 202-618-6975
House Passes Budget with Medical Cannabis Protection Amendment
Rohrabacher-Blumenauer Amendment will Protect Patients from AG Sessions until September
Washington, D.C. — Today, after months of debate and continuing resolutions, the House of Representatives passed its Appropriations package for the fiscal year of 2018. Unlike previous short term measures, this bill will fully fund the government through September 30, 2018. At over 2,200 pages the bill is a massive combination of funding outlays and policy. Due to the hard work of advocates the bill includes the text of the Rohrabacher-Blumenauer amendment.
WASHINGTON, DC — February 28, 2018 — Today the medical cannabis advocacy organization, Americans for Safe Access, released its annual report entitled “Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws.” The report examines the status of states that have passed medical marijuana laws and grades them on a 500 point scale. Forty-six states and three territories have some form of medical cannabis program, meaning approximately 95% of the American population lives in a state with some form of medical cannabis law.
Americans for Safe Access Announces Partnership with Releaf App Aimed at Creating a New Class of Patient-Focused Dispensaries - Americans for Safe Access
Washington, D.C. - February 21, 2018 -- Today, Americans for Safe Access (ASA), a non-profit organization promoting safe and legal access to medical cannabis since 2002, and Releaf App, an experience tracking tool for cannabis patients, officially announced their partnership to empower medical cannabis patients and establish a new class of like-minded U.S. medical cannabis dispensaries.